Using machine learning to guide blood culture use in the ER
Part of Infections clinical trials.
This trial tests whether a machine learning model can help doctors decide when to order blood cultures for patients in the emergency department. It aims to reduce unnecessary tests while still catching infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your ER doctor has decided you need a blood culture.
- You have enough recent lab results and vital signs recorded for the computer to make a prediction.
- You do not have a central line or PICC in place.
- Your current infection is not likely to be endocarditis, spondylodiscitis, or related to a prosthetic device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds and tests a computer (machine-learning) model to predict bloodstream infections based on what happens in the first days of care. It may help doctors start the right antibiotic faster for patients who truly have an infection.
This study tests a new machine learning method to quickly identify bacteria in the blood using special sample bottles. If you are getting blood cultures done already, this may help get results faster.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study tests a computer program that helps doctors choose the best antibiotic sooner for infections like sepsis, pneumonia, or urinary tract infections in hospital wards. It may lead to faster, more effective treatment.
This study tests a new computer program that helps doctors find serious infections (sepsis and bacteremia) earlier in ICU patients. If you join, the program will analyze your health data to see if it can better predict these infections, which could help you get faster treatment.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
Hear when a new Machine Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.